Aescuvest

What is Aescuvest?

Aescuvest is a European venture capital firm headquartered in Frankfurt am Main, Germany, that specializes in the healthtech sector. With a specific focus on Seed-stage investments, Aescuvest supports medical breakthrough innovations aimed at digital drug development, digital devices, and digital detection and diagnosis technologies.

Positioning itself as the leading deal-by-deal VC boutique in healthtech, Aescuvest offers a vigorous selection process and invests in start-ups they believe have exponential growth potential. They facilitate the transition from 'sickcare' to healthcare, with an emphasis on remote monitoring, detection and diagnosis, personalized medicine, and the application of artificial intelligence in healthcare.

The firm's venture capital boutique approach allows investors to co-invest in hand-selected healthtech start-ups. Aescuvest prides itself on providing expert guidance and structuring financing rounds for promising healthtech investment opportunities. Their growing network of partnerships across Europe and the Middle East enables them to source, evaluate, and participate in structuring the financing of promising healthtech start-ups.

Their investment strategy allows investors to build a bespoke portfolio of healthtech start-ups tailored to their personal investment focus.

The minimum investment threshold for Aescuvest is 1,000,000, with a maximum of 5,000,000.

With a portfolio that showcases a range of recent healthtech investments, Aescuvest is firmly embedded in the ecosystem and is recognized for creating the right environment for building strategic healthtech portfolios, supporting like-minded entrepreneurs and investors in increasing patient outcomes, and empowering the sector's hidden gems in Europe and Israel.

What they say:

We invest in medical breakthrough innovations in the areas of: digital drug, digital device and digital detection and diagnosis.